HomeInsights52 Week Low Stocks

Concord Biotech Ltd 52 Week Low

Concord Biotech Ltd 52 Week Low

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

0.9 K

stocks traded

Last Updated time: 05 Nov 14:02 PM

Image

Concord Biotech Ltd

NSE: CONCORDBIO

YEARLOW

1133.55

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Concord Biotech Ltd is ₹ 1133 as of 04 Nov 24.

Company Fundamentals for Concord Biotech Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241812.8
01 Nov 20241857.5
31 Oct 20241836.6
30 Oct 20241807.8
29 Oct 20241818.75
28 Oct 20241828.7
25 Oct 20241805
24 Oct 20241813.75
23 Oct 20241843.9
22 Oct 20241840.8

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Concord Biotech Ltd News Hub

News

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Co...

Read more

29 Aug 202414:30

News

Concord Biotech schedules board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 9 August 2...

Read more

31 Jul 202414:25

News

Concord Biotech to conduct AGM

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will b...

Read more

31 May 202416:57

News

Volumes spurt at Concord Biotech Ltd counter

Inox Wind Ltd, Sumitomo Chemical India Ltd, Doms Industries Ltd, Natco Pharma Ltd are amon...

Read more

28 May 202414:30

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 202419:01

News

Concord Biotech declare Quarterly Result

Concord Biotech will hold a meeting of the Board of Directors of the Company on 23 May 202...

Read more

16 May 202412:02

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Concord Biotech Ltd

Why is it important to track the 52-week low of Concord Biotech Ltd stocks?

Investors should monitor the 52-week low of Concord Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Concord Biotech Ltd stocks hitting a 52-week low?

Factors leading to Concord Biotech Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Concord Biotech Ltd stocks when they hit a 52-week low?

Buying Concord Biotech Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Concord Biotech Ltd stocks?

Investors should monitor the 52-week low of Concord Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Concord Biotech Ltd stock at their 52-week low?

An investor can analyze the reasons for the Concord Biotech Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Concord Biotech Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Concord Biotech Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Concord Biotech Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*